Cogent Biosciences Inc (COGT) — Cash Flow Quality Index

Latest as of December 2019: -3.68x

Cogent Biosciences Inc (COGT) has a Cash Flow Quality Index of -3.68x as of December 2019. Operating cash flow of $-8.45 Million is below net income of $2.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cogent Biosciences Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-3.68x

Operating CF / Net Income

Operating Cash Flow

$-8.45 Million

USD

Net Income

$2.30 Million

USD

Data as of

Dec 2019

Most recent filing

Annual Cash Flow Quality Index for Cogent Biosciences Inc (None–None)

Year-by-year earnings quality comparison for Cogent Biosciences Inc. For live market cap and the full company financial profile, see Cogent Biosciences Inc stock valuation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.